<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="Tab2">
 <label>Table 3.2</label>
 <caption>
  <p>Antiviral activities of defensins</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th align="left">Defensin</th>
    <th align="left">Structure</th>
    <th align="left">Source</th>
    <th align="left">Virus</th>
    <th align="left">Genome</th>
    <th align="left">Antiviral mechanism</th>
    <th align="left">REF</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td align="left">
     <p>HNP-1-3</p>
     <p>(including HNP-1)</p>
    </td>
    <td align="left">α-defensin</td>
    <td align="left">Human</td>
    <td align="left">HSV-2</td>
    <td align="left">dsDNA</td>
    <td align="left">Interacts with viral gb2; prevents binding to target cell; also blocks post-entry events</td>
    <td align="left">Yasin et al. (
     <xref ref-type="bibr" rid="CR153">2004</xref>), Hazrati et al. (
     <xref ref-type="bibr" rid="CR56">2006</xref>)
    </td>
   </tr>
   <tr>
    <td align="left"/>
    <td align="left"/>
    <td align="left"/>
    <td align="left">HPV</td>
    <td align="left">dsDNA</td>
    <td align="left">Blocks virus escape from endocytic vesicles</td>
    <td align="left">Buck et al. (
     <xref ref-type="bibr" rid="CR19">2006</xref>)
    </td>
   </tr>
   <tr>
    <td align="left"/>
    <td align="left"/>
    <td align="left"/>
    <td align="left">VV</td>
    <td align="left">dsDNA</td>
    <td align="left">No antiviral effect</td>
    <td align="left">Howell et al. (
     <xref ref-type="bibr" rid="CR57">2004</xref>)
    </td>
   </tr>
   <tr>
    <td align="left"/>
    <td align="left"/>
    <td align="left"/>
    <td align="left">JCPyV</td>
    <td align="left">dsDNA</td>
    <td align="left">No antiviral effect</td>
    <td align="left">Zins et al. (
     <xref ref-type="bibr" rid="CR158">2014</xref>)
    </td>
   </tr>
   <tr>
    <td align="left"/>
    <td align="left"/>
    <td align="left"/>
    <td align="left">BK virus</td>
    <td align="left">dsDNA</td>
    <td align="left">Inhibits infection; mechanism unknown</td>
    <td align="left">Dugan et al. (
     <xref ref-type="bibr" rid="CR35">2008</xref>)
    </td>
   </tr>
   <tr>
    <td align="left"/>
    <td align="left"/>
    <td align="left"/>
    <td align="left">HAdV A,B1,B2,C</td>
    <td align="left">dsDNA</td>
    <td align="left">Inhibits infection; direct interaction with viral particles preventing uncoating</td>
    <td align="left">Smith et al. (
     <xref ref-type="bibr" rid="CR117">2010</xref>), Bastian and Schäfer (
     <xref ref-type="bibr" rid="CR12">2001</xref>)
    </td>
   </tr>
   <tr>
    <td align="left"/>
    <td align="left"/>
    <td align="left"/>
    <td align="left">CMV</td>
    <td align="left">dsDNA</td>
    <td align="left">Modest direct antiviral effect</td>
    <td align="left">(Daher et al. 
     <xref ref-type="bibr" rid="CR30">1986</xref>)
    </td>
   </tr>
   <tr>
    <td align="left"/>
    <td align="left"/>
    <td align="left"/>
    <td align="left">HIV-1</td>
    <td align="left">ssRNA</td>
    <td align="left">Direct effect on virion; blocks viral gp120–cellular CD4 interaction; blocks host PKC signalling, affecting reverser transcription and integration; increased secretion of C–C chemokines</td>
    <td align="left">Chang et al. (
     <xref ref-type="bibr" rid="CR23">2003</xref>), Demirkhanyan et al. (
     <xref ref-type="bibr" rid="CR33">2012</xref>), Furci (
     <xref ref-type="bibr" rid="CR40">2006</xref>), Wang et al. (
     <xref ref-type="bibr" rid="CR138">2004</xref>), Guo (
     <xref ref-type="bibr" rid="CR53">2004</xref>)
    </td>
   </tr>
   <tr>
    <td align="left"/>
    <td align="left"/>
    <td align="left"/>
    <td align="left">VSIV</td>
    <td align="left">(−)ssRNA</td>
    <td align="left">Direct effect on virus, inhibits infection. mechanism unknown</td>
    <td align="left">Daher et al. (
     <xref ref-type="bibr" rid="CR30">1986</xref>)
    </td>
   </tr>
   <tr>
    <td align="left"/>
    <td align="left"/>
    <td align="left"/>
    <td align="left">HCV</td>
    <td align="left">(+)ssRNA</td>
    <td align="left">HCV core protein activates HNP transcription (antiviral activity untested)</td>
    <td align="left">Aceti et al. (
     <xref ref-type="bibr" rid="CR1">2006</xref>)
    </td>
   </tr>
   <tr>
    <td align="left"/>
    <td align="left"/>
    <td align="left"/>
    <td align="left">Echovirus</td>
    <td align="left">(+)ssRNA</td>
    <td align="left">Lack of direct effect on virion</td>
    <td align="left">Daher et al. (
     <xref ref-type="bibr" rid="CR30">1986</xref>)
    </td>
   </tr>
   <tr>
    <td align="left"/>
    <td align="left"/>
    <td align="left"/>
    <td align="left">Reovirus (type 3)</td>
    <td align="left">dsRNA</td>
    <td align="left">Lack of direct effect on virion</td>
    <td align="left">Daher et al. (
     <xref ref-type="bibr" rid="CR30">1986</xref>)
    </td>
   </tr>
   <tr>
    <td align="left"/>
    <td align="left"/>
    <td align="left"/>
    <td align="left">IAV</td>
    <td align="left">(−)ssRNA</td>
    <td align="left">Inhibition of PKC pathway in host cells; blocks viral replication and protein synthesis; increased uptake and clearance by neutrophils</td>
    <td align="left">Salvatore et al. (
     <xref ref-type="bibr" rid="CR110">2007</xref>), Tecle et al. (
     <xref ref-type="bibr" rid="CR124">2007</xref>)
    </td>
   </tr>
   <tr>
    <td align="left">HNP-4</td>
    <td align="left">α-defensin</td>
    <td align="left">Human</td>
    <td align="left">HSV-2</td>
    <td align="left">dsDNA</td>
    <td align="left">Interacts with heparan sulfate on host cells; prevents viral entry</td>
    <td align="left">Hazrati et al. (
     <xref ref-type="bibr" rid="CR56">2006</xref>)
    </td>
   </tr>
   <tr>
    <td align="left"/>
    <td align="left"/>
    <td align="left"/>
    <td align="left">JCPyV</td>
    <td align="left">dsDNA</td>
    <td align="left">No antiviral effect</td>
    <td align="left">Zins et al. (
     <xref ref-type="bibr" rid="CR158">2014</xref>)
    </td>
   </tr>
   <tr>
    <td align="left"/>
    <td align="left"/>
    <td align="left"/>
    <td align="left">HIV-1</td>
    <td align="left">ssRNA</td>
    <td align="left">Lectin independent antiviral effect; weak interaction with gp120 and CD4</td>
    <td align="left">Wu et al. (
     <xref ref-type="bibr" rid="CR148">2005</xref>)
    </td>
   </tr>
   <tr>
    <td align="left">RMAD3</td>
    <td align="left">Rhesus Macaque α-defensin 3</td>
    <td align="left">Rhesus</td>
    <td align="left">HIV-1</td>
    <td align="left">ssRNA</td>
    <td align="left">Moderate direct antiviral effect</td>
    <td align="left">Tanabe et al. (
     <xref ref-type="bibr" rid="CR121">2004</xref>)
    </td>
   </tr>
   <tr>
    <td align="left">RMAD4</td>
    <td align="left">Rhesus Macaque α-defensin 4</td>
    <td align="left">Rhesus</td>
    <td align="left">HIV-1</td>
    <td align="left">ssRNA</td>
    <td align="left">Blocks viral entry</td>
    <td align="left">Tanabe et al. (
     <xref ref-type="bibr" rid="CR121">2004</xref>)
    </td>
   </tr>
   <tr>
    <td align="left">HD5</td>
    <td align="left">α-defensin</td>
    <td align="left">Human</td>
    <td align="left">HSV-2</td>
    <td align="left">dsDNA</td>
    <td align="left">Interacts with viral gb2; prevents binding to target cell; blocks post-entry events</td>
    <td align="left">Hazrati et al. (
     <xref ref-type="bibr" rid="CR56">2006</xref>)
    </td>
   </tr>
   <tr>
    <td align="left"/>
    <td align="left"/>
    <td align="left"/>
    <td align="left">HPV</td>
    <td align="left">dsDNA</td>
    <td align="left">Blocks virus escape from endocytic vesicles; blocks virus unfolding (host mediated capsid L2 cleavage)</td>
    <td align="left">Yasin et al. (
     <xref ref-type="bibr" rid="CR153">2004</xref>), Hazrati et al. (
     <xref ref-type="bibr" rid="CR56">2006</xref>), Buck et al. (
     <xref ref-type="bibr" rid="CR19">2006</xref>), Gounder et al. (
     <xref ref-type="bibr" rid="CR51">2012</xref>)
    </td>
   </tr>
   <tr>
    <td align="left"/>
    <td align="left"/>
    <td align="left"/>
    <td align="left">JCPyV</td>
    <td align="left">dsDNA</td>
    <td align="left">Binds to viral particles inhibiting genome release</td>
    <td align="left">Zins et al. (
     <xref ref-type="bibr" rid="CR158">2014</xref>), Dugan et al. (
     <xref ref-type="bibr" rid="CR35">2008</xref>)
    </td>
   </tr>
   <tr>
    <td align="left"/>
    <td align="left"/>
    <td align="left"/>
    <td align="left">BK virus</td>
    <td align="left">dsDNA</td>
    <td align="left">Causes aggregation of viral particles, reducing viral attachment to cells</td>
    <td align="left">Zins et al. (
     <xref ref-type="bibr" rid="CR158">2014</xref>), Dugan et al. (
     <xref ref-type="bibr" rid="CR35">2008</xref>)
    </td>
   </tr>
   <tr>
    <td align="left"/>
    <td align="left"/>
    <td align="left"/>
    <td align="left">
     <p>HAdV</p>
     <p>A,B1,B2,C,E</p>
    </td>
    <td align="left">dsDNA</td>
    <td align="left">Inhibits infection by direct interaction with viral particles preventing uncoating</td>
    <td align="left">Gounder et al. (
     <xref ref-type="bibr" rid="CR51">2012</xref>), Smith et al. (
     <xref ref-type="bibr" rid="CR117">2010</xref>)
    </td>
   </tr>
   <tr>
    <td align="left"/>
    <td align="left"/>
    <td align="left"/>
    <td align="left">HIV-1</td>
    <td align="left">ssRNA</td>
    <td align="left">Enhances HIV-1 infection by increasing viral attachment; effects independent on CD4 or viral co-receptors in target cells</td>
    <td align="left">Klotman et al. (
     <xref ref-type="bibr" rid="CR66">2008</xref>), Rapista et al. (
     <xref ref-type="bibr" rid="CR104">2011</xref>)
    </td>
   </tr>
   <tr>
    <td align="left"/>
    <td align="left"/>
    <td align="left"/>
    <td align="left">IAV</td>
    <td align="left">(−)ssRNA</td>
    <td align="left">Increased neutrophil uptake and viral clearance</td>
    <td align="left">Tecle et al. (
     <xref ref-type="bibr" rid="CR124">2007</xref>)
    </td>
   </tr>
   <tr>
    <td align="left">HD6</td>
    <td align="left">α-defensin</td>
    <td align="left">Human</td>
    <td align="left">HSV-2</td>
    <td align="left">dsDNA</td>
    <td align="left">Interacts with heparansulfate on host cells; prevents viral entry</td>
    <td align="left">Hazrati et al. (
     <xref ref-type="bibr" rid="CR56">2006</xref>)
    </td>
   </tr>
   <tr>
    <td align="left"/>
    <td align="left"/>
    <td align="left"/>
    <td align="left">HPV</td>
    <td align="left">dsDNA</td>
    <td align="left">No antiviral effect</td>
    <td align="left">Buck et al. (
     <xref ref-type="bibr" rid="CR19">2006</xref>)
    </td>
   </tr>
   <tr>
    <td align="left"/>
    <td align="left"/>
    <td align="left"/>
    <td align="left">HIV-1</td>
    <td align="left">ssRNA</td>
    <td align="left">Enhances HIV-1 infection by increasing viral attachment; effects independent on CD4 or viral co-receptors In target cells</td>
    <td align="left">Klotman et al. (
     <xref ref-type="bibr" rid="CR66">2008</xref>), Rapista et al. (
     <xref ref-type="bibr" rid="CR104">2011</xref>)
    </td>
   </tr>
   <tr>
    <td align="left">NP-1</td>
    <td align="left">α-defensin</td>
    <td align="left">Rabbit</td>
    <td align="left">HSV-1</td>
    <td align="left">dsDNA</td>
    <td align="left">Direct effect on viral particles; prevents viral entry and VP16 translocation to the nucleus</td>
    <td align="left">Sinha et al. (
     <xref ref-type="bibr" rid="CR115">2003</xref>)
    </td>
   </tr>
   <tr>
    <td align="left"/>
    <td align="left"/>
    <td align="left"/>
    <td align="left">HSV-2</td>
    <td align="left">dsDNA</td>
    <td align="left">Direct effect on viral particles; prevents viral entry and VP16 translocation to the nucleus</td>
    <td align="left">Sinha et al. (
     <xref ref-type="bibr" rid="CR115">2003</xref>)
    </td>
   </tr>
   <tr>
    <td align="left"/>
    <td align="left"/>
    <td align="left"/>
    <td align="left">HIV-1</td>
    <td align="left">ssRNA</td>
    <td align="left">Inhibits HIV infection in transformed cell lines</td>
    <td align="left">Nakashima et al. (
     <xref ref-type="bibr" rid="CR90">1993</xref>)
    </td>
   </tr>
   <tr>
    <td align="left">α-defensins</td>
    <td align="left">α-defensin</td>
    <td align="left">Rat</td>
    <td align="left">HIV-1</td>
    <td align="left">ssRNA</td>
    <td align="left">Inhibits HIV infection in transformed cell lines</td>
    <td align="left">Nakashima et al. (
     <xref ref-type="bibr" rid="CR90">1993</xref>)
    </td>
   </tr>
   <tr>
    <td align="left">α-defensins</td>
    <td align="left">α-defensin</td>
    <td align="left">Guinea pig</td>
    <td align="left">HIV-1</td>
    <td align="left">ssRNA</td>
    <td align="left">Inhibits HIV infection in transformed cell lines</td>
    <td align="left">Nakashima et al. (
     <xref ref-type="bibr" rid="CR90">1993</xref>)
    </td>
   </tr>
   <tr>
    <td align="left">Crp 3</td>
    <td align="left">α-defensin</td>
    <td align="left">Mouse</td>
    <td align="left">HIV-1</td>
    <td align="left">ssRNA</td>
    <td align="left">Moderate increase in HIV infectivity</td>
    <td align="left">Tanabe et al. (
     <xref ref-type="bibr" rid="CR121">2004</xref>)
    </td>
   </tr>
   <tr>
    <td align="left">Crp 4</td>
    <td align="left">α-defensin</td>
    <td align="left">Mouse</td>
    <td align="left">HIV-1</td>
    <td align="left">ssRNA</td>
    <td align="left">Moderate antiviral activity</td>
    <td align="left">Tanabe et al. (
     <xref ref-type="bibr" rid="CR121">2004</xref>)
    </td>
   </tr>
   <tr>
    <td align="left">hBD1</td>
    <td align="left">β-defensin</td>
    <td align="left">Human</td>
    <td align="left">HSV-2</td>
    <td align="left">dsDNA</td>
    <td align="left">No antiviral effect</td>
    <td align="left">Hazrati et al. (
     <xref ref-type="bibr" rid="CR56">2006</xref>)
    </td>
   </tr>
   <tr>
    <td align="left"/>
    <td align="left"/>
    <td align="left"/>
    <td align="left">HPV</td>
    <td align="left">dsDNA</td>
    <td align="left">No antiviral effect</td>
    <td align="left">Buck et al. (
     <xref ref-type="bibr" rid="CR19">2006</xref>)
    </td>
   </tr>
   <tr>
    <td align="left"/>
    <td align="left"/>
    <td align="left"/>
    <td align="left">VV</td>
    <td align="left">dsDNA</td>
    <td align="left">No antiviral effect</td>
    <td align="left">Howell et al. (
     <xref ref-type="bibr" rid="CR57">2004</xref>)
    </td>
   </tr>
   <tr>
    <td align="left"/>
    <td align="left"/>
    <td align="left"/>
    <td align="left">JCPyV</td>
    <td align="left">dsDNA</td>
    <td align="left">No antiviral effect</td>
    <td align="left">Zins et al. (
     <xref ref-type="bibr" rid="CR158">2014</xref>)
    </td>
   </tr>
   <tr>
    <td align="left"/>
    <td align="left"/>
    <td align="left"/>
    <td align="left">BK virus</td>
    <td align="left">dsDNA</td>
    <td align="left">No antiviral effect</td>
    <td align="left">Dugan et al. (
     <xref ref-type="bibr" rid="CR35">2008</xref>)
    </td>
   </tr>
   <tr>
    <td align="left"/>
    <td align="left"/>
    <td align="left"/>
    <td align="left">HAdV (Av1CF2)</td>
    <td align="left">dsDNA</td>
    <td align="left">Inhibits infection; mechanism unknown</td>
    <td align="left">Gropp et al. (
     <xref ref-type="bibr" rid="CR52">1999</xref>)
    </td>
   </tr>
   <tr>
    <td align="left"/>
    <td align="left"/>
    <td align="left"/>
    <td align="left">HIV-1</td>
    <td align="left">ssRNA</td>
    <td align="left">No antiviral effect; not upregulated by virus</td>
    <td align="left">Quiñones-Mateu (
     <xref ref-type="bibr" rid="CR103">2003</xref>)
    </td>
   </tr>
   <tr>
    <td align="left"/>
    <td align="left"/>
    <td align="left"/>
    <td align="left">IAV</td>
    <td align="left">(−)ssRNA</td>
    <td align="left">Increased virus uptake by neutrophils</td>
    <td align="left">Tecle et al. (
     <xref ref-type="bibr" rid="CR124">2007</xref>)
    </td>
   </tr>
   <tr>
    <td align="left"/>
    <td align="left"/>
    <td align="left"/>
    <td align="left">RSV</td>
    <td align="left">(−)ssRNA</td>
    <td align="left">No antiviral effect</td>
    <td align="left">Kota et al. (
     <xref ref-type="bibr" rid="CR67">2008</xref>)
    </td>
   </tr>
   <tr>
    <td align="left"/>
    <td align="left"/>
    <td align="left"/>
    <td align="left">HRV</td>
    <td align="left">(+)ssRNA</td>
    <td align="left">Not induced by virus</td>
    <td align="left">Duits et al. (
     <xref ref-type="bibr" rid="CR36">2003</xref>)
    </td>
   </tr>
   <tr>
    <td align="left">hBD2</td>
    <td align="left">β-defensin</td>
    <td align="left">Human</td>
    <td align="left">HSV-2</td>
    <td align="left">dsDNA</td>
    <td align="left">No antiviral effect</td>
    <td align="left">Hazrati et al. (
     <xref ref-type="bibr" rid="CR56">2006</xref>)
    </td>
   </tr>
   <tr>
    <td align="left"/>
    <td align="left"/>
    <td align="left"/>
    <td align="left">HPV</td>
    <td align="left">dsDNA</td>
    <td align="left">No antiviral effect</td>
    <td align="left">Buck et al. (
     <xref ref-type="bibr" rid="CR19">2006</xref>)
    </td>
   </tr>
   <tr>
    <td align="left"/>
    <td align="left"/>
    <td align="left"/>
    <td align="left">VV</td>
    <td align="left">dsDNA</td>
    <td align="left">No antiviral effect</td>
    <td align="left">Howell et al. (
     <xref ref-type="bibr" rid="CR57">2004</xref>)
    </td>
   </tr>
   <tr>
    <td align="left"/>
    <td align="left"/>
    <td align="left"/>
    <td align="left">JCPyV</td>
    <td align="left">dsDNA</td>
    <td align="left">No antiviral effect</td>
    <td align="left">Zins et al. (
     <xref ref-type="bibr" rid="CR158">2014</xref>)
    </td>
   </tr>
   <tr>
    <td align="left"/>
    <td align="left"/>
    <td align="left"/>
    <td align="left">BK virus</td>
    <td align="left">dsDNA</td>
    <td align="left">Moderate inhibitory effect; mechanism unknown</td>
    <td align="left">Dugan et al. (
     <xref ref-type="bibr" rid="CR35">2008</xref>)
    </td>
   </tr>
   <tr>
    <td align="left"/>
    <td align="left"/>
    <td align="left"/>
    <td align="left">HAdV (5)</td>
    <td align="left">dsDNA</td>
    <td align="left">Moderate inhibitory effect; mechanism unknown</td>
    <td align="left">Bastian and Schäfer (
     <xref ref-type="bibr" rid="CR12">2001</xref>)
    </td>
   </tr>
   <tr>
    <td align="left"/>
    <td align="left"/>
    <td align="left"/>
    <td align="left">HIV-1</td>
    <td align="left">ssRNA</td>
    <td align="left">Inhibits both X4 and R5 infection; downregulates CXC4; inhibits early products of reverse transcription</td>
    <td align="left">Quiñones-Mateu et al. (
     <xref ref-type="bibr" rid="CR103">2003</xref>), Sun et al. (
     <xref ref-type="bibr" rid="CR119">2005</xref>)
    </td>
   </tr>
   <tr>
    <td align="left"/>
    <td align="left"/>
    <td align="left"/>
    <td align="left">IAV</td>
    <td align="left">(−)ssRNA</td>
    <td align="left">Increased uptake by neutrophils</td>
    <td align="left">Tecle et al. (
     <xref ref-type="bibr" rid="CR124">2007</xref>)
    </td>
   </tr>
   <tr>
    <td align="left"/>
    <td align="left"/>
    <td align="left"/>
    <td align="left">RSV</td>
    <td align="left">(−)ssRNA</td>
    <td align="left">Increased secretion; direct effect on viral particles; disruption of the viral envelope</td>
    <td align="left">Kota et al. (
     <xref ref-type="bibr" rid="CR67">2008</xref>)
    </td>
   </tr>
   <tr>
    <td align="left"/>
    <td align="left"/>
    <td align="left"/>
    <td align="left">HRV</td>
    <td align="left">(+)ssRNA</td>
    <td align="left">Induction of expression by virus</td>
    <td align="left">Duits et al. (
     <xref ref-type="bibr" rid="CR36">2003</xref>)
    </td>
   </tr>
   <tr>
    <td align="left">mBD2</td>
    <td align="left">β-defensin</td>
    <td align="left">Mouse</td>
    <td align="left">IAV (PR8)</td>
    <td align="left">(−)ssRNA</td>
    <td align="left">Blocks viral entry to target cells</td>
    <td align="left">Gong et al. (
     <xref ref-type="bibr" rid="CR49">2010</xref>)
    </td>
   </tr>
   <tr>
    <td align="left"/>
    <td align="left"/>
    <td align="left"/>
    <td align="left">DENV-2</td>
    <td align="left">(+)ssRNA</td>
    <td align="left">Induction of expression</td>
    <td align="left">Bustos-Arriaga et al. (
     <xref ref-type="bibr" rid="CR21">2011</xref>)
    </td>
   </tr>
   <tr>
    <td align="left">hBD3</td>
    <td align="left">β-defensin</td>
    <td align="left">Human</td>
    <td align="left">HSV-2</td>
    <td align="left">dsDNA</td>
    <td align="left">Interacts with heparansulfate on host cells and also viral gb2; prevents viral binding</td>
    <td align="left">Hazrati et al. (
     <xref ref-type="bibr" rid="CR56">2006</xref>)
    </td>
   </tr>
   <tr>
    <td align="left"/>
    <td align="left"/>
    <td align="left"/>
    <td align="left">VV</td>
    <td align="left">dsDNA</td>
    <td align="left">Reduced viral DNA-dependent RNA pol expression and plaque formation</td>
    <td align="left">Howell et al. (
     <xref ref-type="bibr" rid="CR57">2004</xref>)
    </td>
   </tr>
   <tr>
    <td align="left"/>
    <td align="left"/>
    <td align="left"/>
    <td align="left">JCPyV</td>
    <td align="left">dsDNA</td>
    <td align="left">Inhibits infection; cytotoxicity towards host cells</td>
    <td align="left">Zins et al. (
     <xref ref-type="bibr" rid="CR158">2014</xref>)
    </td>
   </tr>
   <tr>
    <td align="left"/>
    <td align="left"/>
    <td align="left"/>
    <td align="left">HIV-1</td>
    <td align="left">ssRNA</td>
    <td align="left">Inhibits both X4 and R5 infection; downregulates CXC4; inhibits early products of reverse transcription</td>
    <td align="left">Quiñones-Mateu (
     <xref ref-type="bibr" rid="CR103">2003</xref>), Sun et al. (
     <xref ref-type="bibr" rid="CR119">2005</xref>)
    </td>
   </tr>
   <tr>
    <td align="left"/>
    <td align="left"/>
    <td align="left"/>
    <td align="left">IAV</td>
    <td align="left">(−)ssRNA</td>
    <td align="left">Blockshemagglutinin-mediated viral fusion to host cells</td>
    <td align="left">Leikina et al. (
     <xref ref-type="bibr" rid="CR74">2005</xref>)
    </td>
   </tr>
   <tr>
    <td align="left"/>
    <td align="left"/>
    <td align="left"/>
    <td align="left">SINV</td>
    <td align="left">(+)ssRNA</td>
    <td align="left">Blocks viral fusion with target cells</td>
    <td align="left">Leikina et al. (
     <xref ref-type="bibr" rid="CR74">2005</xref>)
    </td>
   </tr>
   <tr>
    <td align="left">mBD3</td>
    <td align="left">β-defensin</td>
    <td align="left">Mouse</td>
    <td align="left">IAV (PR8)</td>
    <td align="left">(−)ssRNA</td>
    <td align="left">Blocks viral entry to target cells</td>
    <td align="left">Jiang et al. (
     <xref ref-type="bibr" rid="CR65">2012</xref>)
    </td>
   </tr>
   <tr>
    <td align="left">RC1</td>
    <td align="left">Inferred from human θ defensin genes</td>
    <td align="left">Human</td>
    <td align="left">HSV-2</td>
    <td align="left">dsDNA</td>
    <td align="left">Blocks viral attachment; reduced nuclear translocation of VP16</td>
    <td align="left">Yasin et al. (
     <xref ref-type="bibr" rid="CR153">2004</xref>)
    </td>
   </tr>
   <tr>
    <td align="left"/>
    <td align="left"/>
    <td align="left">Human</td>
    <td align="left">HSV-1</td>
    <td align="left">dsDNA</td>
    <td align="left">Direct effect on viral particles; mechanism unknown</td>
    <td align="left">Yasin et al. (
     <xref ref-type="bibr" rid="CR153">2004</xref>)
    </td>
   </tr>
   <tr>
    <td align="left"/>
    <td align="left"/>
    <td align="left">Human</td>
    <td align="left">HIV-1</td>
    <td align="left">ssRNA</td>
    <td align="left">Blocks viral fusion; binds to viral gp41 and glycosylated gp120 and cellular CD4</td>
    <td align="left">Cole et al. (
     <xref ref-type="bibr" rid="CR27">2002</xref>), Gallo et al. (
     <xref ref-type="bibr" rid="CR44">2006</xref>), Wang et al. 
     <xref ref-type="bibr" rid="CR139">(2004</xref>)
    </td>
   </tr>
   <tr>
    <td align="left"/>
    <td align="left"/>
    <td align="left">Human</td>
    <td align="left">HIV-2</td>
    <td align="left">ssRNA</td>
    <td align="left">Modest inhibition of viral fusion</td>
    <td align="left">Gallo et al. (
     <xref ref-type="bibr" rid="CR44">2006</xref>)
    </td>
   </tr>
   <tr>
    <td align="left"/>
    <td align="left"/>
    <td align="left">Human</td>
    <td align="left">SIV</td>
    <td align="left">ssRNA</td>
    <td align="left">Modest inhibition of viral fusion</td>
    <td align="left">Gallo et al. (
     <xref ref-type="bibr" rid="CR44">2006</xref>)
    </td>
   </tr>
   <tr>
    <td align="left"/>
    <td align="left"/>
    <td align="left">Human</td>
    <td align="left">DENV-2</td>
    <td align="left">(+)ssRNA</td>
    <td align="left">Reduces replication by inhibiting viral NS2B-NS3 serine protease</td>
    <td align="left">Rothan et al. 
     <xref ref-type="bibr" rid="CR109">(2012)</xref>
    </td>
   </tr>
   <tr>
    <td align="left">RC2</td>
    <td align="left">Inferred from human θ defensin genes</td>
    <td align="left">Human</td>
    <td align="left">HSV-2</td>
    <td align="left">dsDNA</td>
    <td align="left">Blocks viral attachment; reduced nuclear translocation of VP16</td>
    <td align="left">Yasin et al. (
     <xref ref-type="bibr" rid="CR153">2004</xref>)
    </td>
   </tr>
   <tr>
    <td align="left"/>
    <td align="left"/>
    <td align="left"/>
    <td align="left">HSV-1</td>
    <td align="left">dsDNA</td>
    <td align="left">Direct effect on viral particles; mechanism unknown</td>
    <td align="left">Yasin et al. (
     <xref ref-type="bibr" rid="CR153">2004</xref>)
    </td>
   </tr>
   <tr>
    <td align="left"/>
    <td align="left"/>
    <td align="left"/>
    <td align="left">Baculovirus</td>
    <td align="left">dsDNA</td>
    <td align="left">Blocks viral fusion with target cells, avoids syncytium formation</td>
    <td align="left">Leikina et al. (
     <xref ref-type="bibr" rid="CR74">2005</xref>)
    </td>
   </tr>
   <tr>
    <td align="left"/>
    <td align="left"/>
    <td align="left"/>
    <td align="left">HIV-1</td>
    <td align="left">ssRNA</td>
    <td align="left">Blocks viral fusion; binds to viral glycosylated gp120 and cellular CD4</td>
    <td align="left">Wang et al. (
     <xref ref-type="bibr" rid="CR138">2004</xref>), Cole et al. (
     <xref ref-type="bibr" rid="CR27">2002</xref>)
    </td>
   </tr>
   <tr>
    <td align="left"/>
    <td align="left"/>
    <td align="left"/>
    <td align="left">IAV</td>
    <td align="left">(–)ssRNA</td>
    <td align="left">Prevents hemagglutinin-mediated viral fusion with target cells</td>
    <td align="left">Leikina et al. (
     <xref ref-type="bibr" rid="CR74">2005</xref>)
    </td>
   </tr>
   <tr>
    <td align="left"/>
    <td align="left"/>
    <td align="left"/>
    <td align="left">SINV</td>
    <td align="left">(+)ssRNA</td>
    <td align="left">Prevents viral fusion with target cells</td>
    <td align="left">Leikina et al. (
     <xref ref-type="bibr" rid="CR74">2005</xref>)
    </td>
   </tr>
   <tr>
    <td align="left">RTD1</td>
    <td align="left">Rhesus θ defensin</td>
    <td align="left">Rhesus</td>
    <td align="left">HSV-2</td>
    <td align="left">dsDNA</td>
    <td align="left">No antiviral effect</td>
    <td align="left">Yasin et al. (
     <xref ref-type="bibr" rid="CR153">2004</xref>)
    </td>
   </tr>
   <tr>
    <td align="left"/>
    <td align="left"/>
    <td align="left"/>
    <td align="left">HSV-1</td>
    <td align="left">dsDNA</td>
    <td align="left">No antiviral effect</td>
    <td align="left">Yasin et al. (
     <xref ref-type="bibr" rid="CR153">2004</xref>)
    </td>
   </tr>
   <tr>
    <td align="left"/>
    <td align="left"/>
    <td align="left"/>
    <td align="left">HIV-1 (various isolates)</td>
    <td align="left">ssRNA</td>
    <td align="left">Moderate direct antiviral effect; mechanism unknown</td>
    <td align="left">Wang et al. (
     <xref ref-type="bibr" rid="CR138">2004</xref>)
    </td>
   </tr>
   <tr>
    <td align="left"/>
    <td align="left"/>
    <td align="left"/>
    <td align="left">SARScoV</td>
    <td align="left">(+)ssRNA</td>
    <td align="left">Immunomodulatory effect; reduction in lung cytokine secretion</td>
    <td align="left">Wohlford-Lenane et al. (
     <xref ref-type="bibr" rid="CR143">2009</xref>)
    </td>
   </tr>
   <tr>
    <td align="left">RTD2</td>
    <td align="left">Rhesus θ defensin</td>
    <td align="left">Rhesus</td>
    <td align="left">HSV-2</td>
    <td align="left">dsDNA</td>
    <td align="left">Moderate antiviral effect; mechanism unknown</td>
    <td align="left">Yasin et al. (
     <xref ref-type="bibr" rid="CR153">2004</xref>)
    </td>
   </tr>
   <tr>
    <td align="left"/>
    <td align="left"/>
    <td align="left"/>
    <td align="left">HSV-1</td>
    <td align="left">dsDNA</td>
    <td align="left">No antiviral effect</td>
    <td align="left">Yasin et al. (
     <xref ref-type="bibr" rid="CR153">2004</xref>)
    </td>
   </tr>
   <tr>
    <td align="left"/>
    <td align="left"/>
    <td align="left"/>
    <td align="left">HIV-1 (various isolates)</td>
    <td align="left">ssRNA</td>
    <td align="left">Moderate direct antiviral effect; mechanism unknown</td>
    <td align="left">Wang et al. (
     <xref ref-type="bibr" rid="CR138">2004</xref>)
    </td>
   </tr>
   <tr>
    <td align="left">RTD3</td>
    <td align="left">Rhesus θ defensin</td>
    <td align="left">Rhesus</td>
    <td align="left">HSV-2</td>
    <td align="left">dsDNA</td>
    <td align="left">Direct effect on viral particles; cytotoxicity towards host cell</td>
    <td align="left">Yasin et al. (
     <xref ref-type="bibr" rid="CR153">2004</xref>)
    </td>
   </tr>
   <tr>
    <td align="left"/>
    <td align="left"/>
    <td align="left"/>
    <td align="left">HSV-1</td>
    <td align="left">dsDNA</td>
    <td align="left">Direct effect on viral particles; mechanism unknown</td>
    <td align="left">Yasin et al. (
     <xref ref-type="bibr" rid="CR153">2004</xref>)
    </td>
   </tr>
   <tr>
    <td align="left"/>
    <td align="left"/>
    <td align="left"/>
    <td align="left">HIV-1 (various isolates)</td>
    <td align="left">ssRNA</td>
    <td align="left">Moderate direct antiviral effect; mechanism unknown</td>
    <td align="left">Wang et al. (
     <xref ref-type="bibr" rid="CR138">2004</xref>)
    </td>
   </tr>
  </tbody>
 </table>
</table-wrap>
